Anduril’s valuation trajectory reflects accelerating revenue growth to $2.2 billion in 2025—more than double the prior year—with company targets near $4.3 billion for 2026, supported by major U.S. Army, Air Force, and international contracts including a potential $20 billion enterprise framework. The May 2026 $5 billion Series H round established a $61 billion post-money valuation, roughly doubling the June 2025 mark, while secondary trading on Nasdaq Private Market showed levels near $108 billion by early September amid ongoing discussions of further rounds targeting $100 billion or higher. Defense spending priorities, manufacturing scale-up at facilities like Arsenal-1, and institutional interest in autonomous systems continue to support elevated multiples relative to traditional primes, though outcomes by year-end hinge on contract execution, additional capital raises, and broader market sentiment for private defense tech.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоNPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time.
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Открытие рынка: May 19, 2026, 1:01 AM ET
Кто определяет исход
0x65070BE91...NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for all business dates in the specified period by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the data available.
If NPM ceases publishing relevant data prior to the end of the specified period, this market will resolve based on the NPM data published for the period prior to the cessation of coverage, as well as any applicable public market capitalization data following an IPO or direct listing.
If the company completes an IPO or direct listing before the end of the specified period, this market will consider, in addition to the relevant NPM valuations published between market creation and the IPO or direct listing date, the valuation implied by the official IPO or direct listing price, and the company's public market capitalization between the IPO or direct listing date and the end of the specified period.
Public market capitalization will be determined using the highest/lowest official regular-hours trading price published for the company's primary listed common equity on its primary exchange for any trading day during the specified period, multiplied by the company's total outstanding common shares at the relevant time.
If the listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If the listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only NPM valuations and applicable public market capitalizations achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for this market is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
Кто определяет исход
0x65070BE91...Anduril’s valuation trajectory reflects accelerating revenue growth to $2.2 billion in 2025—more than double the prior year—with company targets near $4.3 billion for 2026, supported by major U.S. Army, Air Force, and international contracts including a potential $20 billion enterprise framework. The May 2026 $5 billion Series H round established a $61 billion post-money valuation, roughly doubling the June 2025 mark, while secondary trading on Nasdaq Private Market showed levels near $108 billion by early September amid ongoing discussions of further rounds targeting $100 billion or higher. Defense spending priorities, manufacturing scale-up at facilities like Arsenal-1, and institutional interest in autonomous systems continue to support elevated multiples relative to traditional primes, though outcomes by year-end hinge on contract execution, additional capital raises, and broader market sentiment for private defense tech.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено




Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы